Integra LifeSciences Holdings Corporation
IART · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $3 | $5 | $6 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $3 | $5 | $6 | $7 |
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | 4.5% | -1% | 1% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 54.8% | 57.4% | 62.3% | 61.2% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 12% | 16.6% | 24.7% | 23.7% |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -0.4% | 4.4% | 11.6% | 11% |
| EPS Diluted | -0.09 | 0.84 | 2.16 | 1.98 |
| % Growth | -110.7% | -61.1% | 9.1% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |